None listed
Conditions
Interventions
Parecoxib sodium Type of group
Parecoxib sodium 40 mg IV administered at the time of the last suture.
Group name:placebo Type of group
Placebo saline solution administered at the time of the last suture
Sponsors
PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,
Eligibility
Inclusion criteria
Inclusion criteria: 1.- Men or women between 18 and 75 years of age. 2.- The patient has a body weight of 50 to 120 kg 3.- The patient requires an elective laparoscopic cholecystectomy. 4.- A procedure is anticipated under an ambulatory patient scheme.
Exclusion criteria
Exclusion criteria: The patient is scheduled to undergo some other surgical procedure that is expected to produce a greater degree of surgical traction than laparoscopic cholecystectomy alone. Acute preoperative pain other than biliary colic. A condition of chronic pain that requires chronic treatment and / or which, in the opinion of the Investigator, may affect pain assessments or the response to therapy. The patient has any type of cognitive impairment that, in the opinion of the Investigator, would impede participation in the study or adherence to the procedures required in the protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome name:The total amount of Fentanyl consumed in the first 6 hours after surgery Measure:The total amount of Fentanyl consumed in the first 6 hours after surgery Timepoints:6 first hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome name:The amount of Fentanyl consumed during the operation and during each of the first six hours after the operation Measure:The amount of Fentanyl consumed during the operation and during each of the first six hours after the operation Timepoints:6 first hours | — |
Countries
Canada, Chile, Colombia, Mexico, Peru
Outcome results
None listed